Overview

PREVENTion of Clot in Orthopaedic Trauma

Status:
Recruiting

Trial end date:
2022-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare aspirin versus low-molecular weight heparin (LMWH) (Enoxaparin) as a thromboprophylaxis in patients who sustain a fracture.

Phase:

Phase 3

Details

Lead Sponsor:

Major Extremity Trauma Research Consortium

Collaborator:

Patient-Centered Outcomes Research Institute

Treatments:

Aspirin
Calcium heparin
Dalteparin
Enoxaparin
Heparin
Heparin, Low-Molecular-Weight
Tinzaparin